Preventing nausea and vomiting from chemotherapy
Part of Cancer clinical trials.
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are about to get chemotherapy that commonly causes nausea and vomiting.
- You have been prescribed an anti-nausea regimen that includes HR20013.
- If you have mild to moderate liver problems, you might join a special group.
- You are not pregnant or breastfeeding.
- You are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
This study tests an anti-nausea drug (nano-crystalline megestrol acetate) to see if it helps prevent nausea and vomiting caused by chemotherapy in people with stomach cancer. If you are starting your first chemotherapy, this may help you feel better during treatment.
This trial tests whether a combination of two anti-nausea drugs (fosrolapitant and palonosetron) can better prevent nausea and vomiting caused by Trastuzumab Rezetecan. If you are starting this cancer treatment, you may be able to join.
This early-stage study tests a new medicine called QLM2010 to see how the body absorbs it. It's for healthy adults and will help determine the right dose for future patients.
This study tests whether acupuncture can reduce nausea and vomiting that often occur after a stem cell transplant. If you are scheduled for a transplant, this treatment might help you feel better during recovery.
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
Hear when a new Nausea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.